Medelis is a full service, specialty oncology contract research organization. We provide sponsors with a highly skilled and proactive oncology clinical trial management team to design and manage phase I through phase III oncology clinical trials in North America and Europe.
Get the comfort of an experienced, dedicated team by your side throughout your trial. We’ll get your study completed on time and on budget.
Oncology trials are complex. We specialize in oncology, and our entire team has deep oncology trial experience and expertise — from our world-class medical advisory board to our clinical team members and medical personnel. This critical first-hand experience in the complex issues often associated with oncology clinical trials means that highly experienced resources will be working on your study.
We’ve handled most targets within oncology, including many complex immuno-oncology studies. Whether it’s a standard dose-escalation phase I trial or a complex rescue of a phase III trial, chances are that our team has handled it before.
We’re a single-source oncology contract research organization for clinical trial planning, trial management and drug development planning for sponsors running clinical studies in North America and Europe.
Our services:
Our clinical team’s comprehension of the complex issues of oncology trials translates into better problem identification, decision making and superior results. We value innovation, and our experience allows us to work smarter, to maximize cost and time efficiencies on your trial.
We’re flexible, collaborative and proactive, and able to quickly adapt to study challenges or changes in the regulatory or competitive environment. This helps to speed a drug to market, and provides the decision support to determine your next clinical move.
The content in this guide is designed for CMOs, VPs and Directors of Clinical Development, the clinical operations team and any others involved in designing and managing immuno-oncology studies.
A GUIDE FOR CHOOSING THE RIGHT IMMUNO-ONCOLOGY CRO
We’d love to hear from you, and can provide feedback about your study design, investigators and patient recruitment, indications, and data collection.